702798009: Linagliptin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with hydrolase inhibitor mechanism of action (substance)\Peptide hydrolase inhibitor\Substance with dipeptidyl peptidase IV inhibitor mechanism of action (substance)\Linagliptin (substance)

\Drug or medicament (substance)\Linagliptin (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Piperidine\Linagliptin (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound (substance)\Quinazoline (substance)\Linagliptin (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound (substance)\Pyridine and/or pyridine derivative\Piperidine\Linagliptin (substance)
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Piperidine\Linagliptin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Linagliptin (substance)	Is a	Oral hypoglycemic	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Linagliptin (substance)	Is a	Substance with dipeptidyl peptidase IV inhibitor mechanism of action (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Linagliptin (substance)	Has disposition	Dipeptidyl peptidase IV inhibitor (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Linagliptin (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Linagliptin (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Linagliptin (substance)	Is a	Piperidine	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Linagliptin (substance)	Is a	Quinazoline (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Linagliptin (substance)	Is a	Drug or medicament (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing linagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Linagliptin 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing empagliflozin and linagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Linagliptin- and metformin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing linagliptin and metformin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Linagliptin 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Linagliptin 5 mg oral tablet	Has basis of strength substance (attribute)	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Linagliptin 5 mg oral tablet	Has precise active ingredient	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Linagliptin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Empagliflozin and linagliptin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only linagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Linagliptin and metformin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Linagliptin and metformin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only linagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only empagliflozin and linagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing empagliflozin and linagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3006132016	Linagliptin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3006177019	Linagliptin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3006132016	Linagliptin (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3006132016	Linagliptin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3006177019	Linagliptin	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3006177019	Linagliptin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
49591000195118	linagliptin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
63771000195117	Linagliptin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
820861000172112	linagliptine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
820861000172112	linagliptine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
49591000195118	linagliptin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
63771000195117	Linagliptin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module